Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 2
2020 4
2021 3
2022 6
2023 1
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Aging-associated and CD4 T-cell-dependent ectopic CXCL13 activation predisposes to anti-PD-1 therapy-induced adverse events.
Tsukamoto H, Komohara Y, Tomita Y, Miura Y, Motoshima T, Imamura K, Kimura T, Ikeda T, Fujiwara Y, Yano H, Kamba T, Sakagami T, Oshiumi H. Tsukamoto H, et al. Among authors: imamura k. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2205378119. doi: 10.1073/pnas.2205378119. Epub 2022 Jul 11. Proc Natl Acad Sci U S A. 2022. PMID: 35858347 Free PMC article.
Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors.
Tomita Y, Goto Y, Sakata S, Imamura K, Minemura A, Oka K, Hayashi A, Jodai T, Akaike K, Anai M, Hamada S, Iyama S, Saruwatari K, Saeki S, Takahashi M, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: imamura k. Oncoimmunology. 2022 May 27;11(1):2081010. doi: 10.1080/2162402X.2022.2081010. eCollection 2022. Oncoimmunology. 2022. PMID: 35655708 Free PMC article.
Association of Clostridium butyricum Therapy Using the Live Bacterial Product CBM588 with the Survival of Patients with Lung Cancer Receiving Chemoimmunotherapy Combinations.
Tomita Y, Sakata S, Imamura K, Iyama S, Jodai T, Saruwatari K, Hamada S, Akaike K, Anai M, Fukusima K, Takaki A, Tsukamoto H, Goto Y, Motozono C, Sugata K, Satou Y, Ueno T, Ikeda T, Sakagami T. Tomita Y, et al. Among authors: imamura k. Cancers (Basel). 2023 Dec 21;16(1):47. doi: 10.3390/cancers16010047. Cancers (Basel). 2023. PMID: 38201474 Free PMC article.
Small-cell Lung Cancer Associated with SAPHO Syndrome.
Imamura K, Sakata S, Sakamoto Y, Saeki S. Imamura K, et al. Intern Med. 2018 Jan 1;57(1):149-151. doi: 10.2169/internalmedicine.9162-17. Epub 2017 Oct 16. Intern Med. 2018. PMID: 29033438 Free PMC article. No abstract available.
Pembrolizumab-related Immune Thrombocytopenia in a Patient with Lung Adenocarcinoma Treated by Radiotherapy: Potential Immune-related Adverse Event Elicited by Radiation Therapy.
Tamanoi D, Saruwatari K, Imamura K, Sato R, Jodai T, Hamada S, Tomita Y, Saeki S, Ueno S, Yonemura Y, Ichiyasu H, Sakagami T. Tamanoi D, et al. Among authors: imamura k. Intern Med. 2022 Jun 1;61(11):1731-1734. doi: 10.2169/internalmedicine.7581-21. Epub 2021 Nov 13. Intern Med. 2022. PMID: 34776479 Free PMC article.
18 results